Recombinant CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody

Product Sizes

100 ug

£671.00

RBM2-1390-P1ABX-100UG

About this Product

SKU:: RBM2-1390-P1ABX
Application:: Immunohistochemistry
translate.label.attr.clone:: CA19.9/1390R
Clonality:: Monoclonal
Extra Details:: CA19-9; a carbohydrate epitope expressed on a high MW (400kDa) mucin glycoprotein; is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues; sialyl Lewisa antigen is present in ductal epithelium of the breast; kidney; salivary gland; and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas; including adenocarcinomas of the stomach; intestine; and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially; CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed; paraffin-embedded tissues.
Host:: Rabbit
Immunogen:: Purified human CA19-9 protein
Isotype:: IgG
Molecular Weight:: >400kDa
Shipping Conditions:: Blue Ice
Storage Conditions:: Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
Supplier:: NeoBiotechnologies
Type:: Antibodies: Monoclonal Antibody

Basket